AzTrials
AzTrials

Morbid ObesityNCT02406976

Effect Physical Exercise in Morbid Obesity

A study testing G1 -Exercise and G2- Exercise and Lifestyle in people with Morbid Obesity, run by Hospital de Clinicas de Porto Alegre at 1 site in Brazil.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

This objective study to verify the effect of physical training with and without behavioral cognitive therapy, compared with controls, in functional capacity and cardio-metabolic profile in individuals with morbidly obese Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Morbid Obesity
What is being tested?
G1 -Exercise and G2- Exercise and Lifestyle
Could I receive a placebo?
No, everyone receives an active treatment
How many people
60 participants
Where
1 siteBrazil
Study dates
Aug 2010to Nov 2018
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Individuals with morbid obesity
  • Individuals do not have contraindications to practice low-intensity exercise.

Who cannot join

  • Contraindications to physical exercise
  • Cardiovascular disease with reduced functional capacity (class III and IV of the New York Heart Association)
  • Orthopedic problems
  • Severe retinopathy
  • Severe neuropathy
  • Drug addicts and severe mental illness
  • High blood pressure or metabolic decompensation

Trial locations and contacts

1 site in 1 country.

Brazil1 site
  • Hospital de Clínicas de Porto Alegre

    Porto Alegre, Rio Grande do Sul, 90035 903

Other trials in Brazil

About this study

Official title: Effect of Physical Exercise on Different Approaches to Treatment of Morbid Obesity

This objective study to verify the effect of physical training with and without behavioral cognitive therapy, compared with controls, in functional capacity and cardio-metabolic profile in individuals with morbidly obese

Read the detailed description

This study is a Randomized Clinical Trial, with individuals with morbid obesity, and will be consists of 3 groups:

  1. Group 1 (G1 EXERCISE): This group will participate in an physical exercise program twice a week in hospital.
  2. Group 2 (G2 - LIFESTYLE AND EXERCISE): This groups will receive the same G1 intervention associated with a weekly group followed up with techniques of cognitive behavioral therapy with a psychologist
  3. Group 3 (G3 - CONTROL): This group will keep medical appointments information and routine procedure in the hospital.

Will be included in study the individuals with morbid obesity who do not have contraindications to practice low-intensity exercise.

Exclusion criteria are contraindications to physical exercise, individuals with cardiovascular disease with reduced functional capacity (class III and IV of the New York Heart Association), orthopedic problems, severe retinopathy, severe neuropathy, drug addicts and severe mental illness, metabolic or blood pressure decompensated.

Conditions
Morbid Obesity
Being tested
G1 -Exercise, G2- Exercise and Lifestyle, G3- Control
Keywords
Exercise, Morbidity Obesity
Medical subject headings
Obesity, Morbid, Motor Activity

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • G1 -ExerciseOther

    20 minutes of aerobic exercises of low intensity (2-4 on the Borg scale) in the rhythm of different songs that encourage their implementation. After these exercises will be performed five minutes of stretching exercises.

    Furthermore the similar treatment to G3.

  • G2- Exercise and LifestyleBehavioural

    Exercise more techniques of cognitive behavioral therapy based on principles of learning, in order to promote and maintain new healthy behaviors and the reduction or elimination of undesirable conduct.

    Furthermore the similar treatment to G3.

  • G3- ControlOther

    Routine treatment in outpatient of bariatric surgery. Consists of individual consultations and 05 (five) information meetings organized by the multidisciplinary team composed by the surgeon, endocrinologist, psychologist, psychiatrist, nutritionist, physical education teacher, pulmonologist, cardiologist and nurse. The G1 and G2 will also receive this intervention.

Study groups in NCT02406976
Study groupRoleWhat they receive
G1- EXERCISEExperimentalThe group will Participate in an physical exercise program twice a week. This program consists of 20 minutes of aerobic exercises of low intensity (2-4 on the Borg scale) in the rhythm of different songs that encourage their implementation. After these exercises will be performed five minutes of stretching exercises.
Receives: Other: G1 -Exercise; Other: G3- Control
G2- EXERCISE AND LIFESTYLEExperimentalThis groups will receive the same intervention of G1 group, associated with the weekly group with a psychologist. These groups worked techniques of cognitive behavioral therapy based on principles of learning, in order to promote and maintain new healthy behaviors, as well as the reduction or elimination of undesirable conduct.
Receives: Behavioral: G2- Exercise and Lifestyle; Other: G3- Control
G3- CONTROLActive comparatorThis group will keep the routine treatment in outpatient of bariatric surgery. This treatment consists of individual consultations and 05 (five) information meetings organized by the multidisciplinary team composed by the surgeon, endocrinologist, psychologist, psychiatrist, nutritionist, physical education teacher, pulmonologist, cardiologist and nurse. The G1 and G2 will also receive this intervention.
Receives: Other: G3- Control

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change in Weight Loss

    Measured: baseline and Four months

Secondary outcomes (2)
  1. Metabolic Parameters (composite)

    Metabolic parameters will be evaluated using total cholesterol, HDL, triglycerides and glucose (Assessment at baseline and 4 months).

    Measured: baseline and Four months

  2. Six minute walk test (6MWT)

    Functional capacity will be evaluated using the six minute walk test (6MWT)

    Measured: baseline and Four months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted2 Apr 2015 (estimated)
  2. Study startAug 2010
  3. Primary completionNov 2015
  4. Study completionNov 2018 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
60 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02406976
Sponsor's protocol ID
10-0328
Status last verified
Mar 2017
First submitted
30 Mar 2015
Last updated
14 Mar 2017
Results posted
No
Data monitoring committee
No
Individual data sharing
Undecided

Publications

  • Marcon ER, Gus I, Neumann CR. [Impact of a minimum program of supervised exercises in the cardiometabolic risk in patients with morbid obesity]. Arq Bras Endocrinol Metabol. 2011 Jun;55(5):331-8. doi: 10.1590/s0004-27302011000500006. Portuguese.

    PubMed 21881816
  • Fonseca Jr SJ, et al. Exercício Físico e Obesidade Mórbida: Uma Revisão Sistemática. ABCD Arq Bras Cir Dig 2013;26(Suplemento 1):67-73

Questions about this trial

What is this clinical trial studying?

A study testing G1 -Exercise and G2- Exercise and Lifestyle in people with Morbid Obesity, run by Hospital de Clinicas de Porto Alegre at 1 site in Brazil.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 7 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 14 Mar 2017. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Brazil. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change in Weight Loss (time frame: baseline and Four months). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT02406976, which also lists 2 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 14 Mar 2017.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in